Author:
Liu Jiayue,Liu Ying,Li Xiaoliang
Abstract
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age. Its clinical characteristics are mainly oligo-ovulation or anovulation, hyperandrogenemia (HA) and insulin resistance (IR). PCOS is considered to be one of the main causes of infertility in women of childbearing age, and its pathogenesis is still unclear. Intestinal flora, known as the “second genome” of human beings, is closely related to metabolic diseases, immune diseases and infectious diseases. At the same time, mounting evidence suggests that intestinal flora can regulate insulin synthesis and secretion, affect androgen metabolism and follicular development, and is involved in the occurrence of chronic inflammation and obesity. The imbalance of intestinal flora is caused by the abnormal interaction between intestinal flora and host cells caused by the change of intestinal microbial diversity, which is related to the occurrence and development of PCOS. The adjustment of intestinal flora may be a potential direction for the treatment of PCOS.
Subject
Endocrinology, Diabetes and Metabolism
Reference94 articles.
1. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment;Escobar-Morreale;Nat Rev Endocrinol,2018
2. Fundamental concepts and novel aspects of polycystic ovarian syndrome: Expert consensus resolutions;Aversa;Front Endocrinol (Lausanne),2020
3. Androgen excess in women: experience with over 1000 consecutive patients;Azziz;J Clin Endocrinol Metab,2004
4. Controversies in the pathogenesis, diagnosis and treatment of PCOS: Focus on insulin resistance, inflammation, and hyperandrogenism;Armanini;Int J Mol Sci,2022
5. Epidemiology, diagnosis, and management of polycystic ovary syndrome;Sirmans;Clin Epidemiol,2013
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献